NCT07506733 Effects of Different Graston Technique Application Speeds on Trapezius Muscle Stiffness, Pressure Pain Threshold, Pain, and Muscle Oxygenation in Patients With Bruxism
| NCT ID | NCT07506733 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gazi University |
| Condition | Bruxism |
| Study Type | INTERVENTIONAL |
| Enrollment | 34 participants |
| Start Date | 2025-03-25 |
| Primary Completion | 2026-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 34 participants in total. It began in 2025-03-25 with a primary completion date of 2026-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized crossover study aims to address an important gap in manual therapy by examining the acute physiological effects of different Graston Technique application speeds (60 BPM vs. 120 BPM) on the dominant upper trapezius muscle in patients with bruxism. Although the Graston Technique is widely used, the specific impact of application speed on parameters such as muscle stiffness, muscle oxygenation, pressure pain threshold, and pain intensity remains under-investigated. By utilizing a crossover design with a 1-week washout period, this study allows for a precise within-subject comparison of the two speeds. The findings will clarify the optimal application frequency, providing objective data to guide the development of more effective, evidence-based manual therapy protocols for bruxism management.
Eligibility Criteria
Inclusion Criteria: * Diagnosed with bruxism. * Aged 18-55 years. * Presence of trigger points in the trapezius muscle, according to the criteria defined by Travell and Simons. Exclusion Criteria: * Acute tears, tendon ruptures, or severe muscle injuries. * Conditions that prevent the application of the Graston Technique (e.g., skin lesions, open wounds, infections). * Having received botox injections in the temporomandibular joint (TMJ) region within the last 6 months. * Psychological disorders that may affect participation or measurements.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07506733 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 55 Years, studying Bruxism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07506733 currently recruiting?
Yes, NCT07506733 is actively recruiting participants. Contact the research team at fztfadimegulcan@gmail.com for enrollment information.
Where is the NCT07506733 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07506733 clinical trial?
NCT07506733 is sponsored by Gazi University. The trial plans to enroll 34 participants.